| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,253 |
2,080 |
$489K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,421 |
1,236 |
$350K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
424 |
368 |
$125K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,541 |
2,289 |
$102K |
| 80053 |
Comprehensive metabolic panel |
1,828 |
1,644 |
$83K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
415 |
345 |
$81K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
309 |
269 |
$30K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
698 |
567 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
206 |
203 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
336 |
305 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
1,848 |
1,576 |
$15K |
| 81001 |
|
914 |
832 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
136 |
130 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
339 |
330 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
274 |
242 |
$10K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
46 |
45 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
75 |
67 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
202 |
177 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
355 |
165 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
98 |
93 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
82 |
76 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
37 |
24 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14 |
12 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
125 |
117 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
39 |
38 |
$3K |
| 36592 |
|
39 |
38 |
$2K |
| J3490 |
Unclassified drugs |
194 |
126 |
$2K |
| 97597 |
|
44 |
13 |
$2K |
| 85027 |
|
31 |
26 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28 |
27 |
$1K |
| 85610 |
|
50 |
46 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
49 |
45 |
$1K |
| 83735 |
|
39 |
31 |
$1K |
| 83605 |
|
26 |
25 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
93 |
83 |
$1K |
| 87077 |
|
29 |
28 |
$898.82 |
| 80306 |
|
29 |
25 |
$813.59 |
| 86140 |
|
29 |
28 |
$658.19 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$564.67 |
| 87186 |
|
13 |
12 |
$498.36 |
| 80061 |
Lipid panel |
12 |
12 |
$444.00 |
| 82077 |
|
21 |
15 |
$439.06 |
| 87088 |
|
13 |
12 |
$382.48 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$376.87 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
25 |
$322.42 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
14 |
14 |
$196.82 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16 |
13 |
$142.32 |
| A9270 |
Non-covered item or service |
55 |
26 |
$0.00 |